Exact Leaders Driving Cancer Detection

2
Exact Sciences is fueled by passion, innovation and Madison’s
entrepreneurial spirit.
People join Exact Sciences to generate real change. And together we
have, pairing creativity with rigorous science to produce Cologuard®
,
then proving its performance in one of the largest clinical trials of
its kind.
We began with strong science and successfully applied it to the
development of a test that is changing human behavior—how people
are screened for today’s second deadliest cancer. We built a flexible lab
and customer care center that can be scaled to take on other cancers
through early detection. And we did it all because of the remarkable
people of Exact Sciences.
There is a new model for success.
Meet the leadership team that is making it happen.

Joined Exact Sciences: 2009
Key Responsibility: Oversee the company’s strategy in cooperation
with the board and investors, create and foster a culture of
collaboration and innovation, build a strong leadership team and
ensure company resources are properly allocated to create the
most value
Previous Employment: chief executive officer, president, Third
Wave Technologies; intellectual property counsel, GE Healthcare;
chief operating officer, venture-backed technology companies;
intellectual property litigator, McDermott Will & Emory; partner,
Pattishall, McAuliffe, Newbury, Hilliard and Geraldson
Education: JD, University of Michigan Law School;
BS, Michigan State University
What excites me most about working at Exact Sciences? Solving
hard problems with exceptional people. It’s incredibly energizing
to know that our collective ability and experience is making a
real difference in the early detection of cancer, a space in which
few companies have been able to carve out a leadership position.
I’m just as excited that we’re putting our skills and know-how to
work bringing other products to market where we can make a
similar difference.
The mission we’ve outlined and the challenges in front of us put
Exact Sciences in a unique leadership position to help win the
war on cancer through early detection.
KEVIN C O N R O Y
C H A I R M A N O F T H E B O A R D ,
C H I E F E X E C U T I V E O F F I C E R A N D P R E S I D E N T

4
Key Responsibility: Drive commercial execution while achieving
excellent service in operations and the lab
Previous Employment: chief financial officer, Third Wave
Technologies; director of corporate strategy & new ventures, Nalco;
brand management, Kraft Foods
Education: MBA, Kellogg Graduate School of Management,
Northwestern University; BA, University of Chicago
We are working to establish Cologuard as a key frontline defense to
curb the incidence and mortality of colorectal cancer. But for Exact
Sciences, the challenge of taking on colon cancer isn’t enough.
Our unique skillset used to develop and commercialize tests that
detect cancer early can be leveraged to fight lung, pancreatic and
esophageal cancers as well.
All of us are excited that these efforts are making a
real difference in the lives of people across the country.
We’re off to a strong start and look forward to achieving great
things in the future.
MANEESH A R O R A
S E N I O R V I C E P R E S I D E N T A N D C H I E F O P E R A T I N G O F F I C E R

Key Responsibility: Oversee the company’s research and product
development organization
Previous Employment: senior vice president of research and
development, Nanogen, Inc.; vice president research and
development, Gen-Probe Inc.; co-founder and vice president
of product development, Matritech, Inc.; Ciba Corning
Diagnostics Corp.
Education: PhD, BA (Honors), University of Manchester, England
All of us at Exact Sciences take great pride in what we do. It’s that
pride in our work that has enabled all the accomplishments that
led to the launch of Cologuard and is fueling the future of the
company. I am proud to have been a member of the Exact Sciences
team during the years that drove the development and FDA approval
of Cologuard. I’m confident that even bigger things lie ahead.
GRAHAM L I D G A R D
C H I E F S C I E N C E O F F I C E R

6
Key Responsibility: Serve as chief legal officer
Previous Employment: managing partner, K&L Gates; general
counsel, Blue Rhino Corporation; associate general counsel,
GE Medical Systems; partner, Smith Anderson
Education: JD, Columbia Law School; BS, University of North
Carolina, Chapel Hill
Industry Organizations: North Carolina Bar Association;
secretary and treasurer, Business Law Council
t’s exciting to be part of an organization that is playing a major role
in the eradication of colorectal cancer. And I should know: I took
the test shortly after turning 50 and had a positive result. A
subsequent colonoscopy confirmed that I had precancerous lesions.
Cologuard made it easy for me to be screened, and as it turned out,
I didn’t have time to procrastinate!
SCOTT C O W A R D
S E N I O R V I C E P R E S I D E N T,
G E N E R A L C O U N S E L A N D S E C R E T A R Y

Key Responsibility: Oversee all laboratory operations
Previous Employment: vice president, division manager, integrated
oncology and genetics, ARUP Laboratories
Education: MBA, Westminster College; BS, Kansas State University
Industry Organizations: past president, Utah chapter, Clinical
Laboratory Management Association (CLMA); National CLMA;
Association of Molecular Pathology (AMP); American Society of
Clinical Laboratory Science (ASCLS)
At Exact Sciences, I’m working with an incredible team of dedicated
industry leaders and laboratory professionals. I’m proud that we’ve
created a nationally accredited clinical laboratory to offer all the
services related to Cologuard, from processing to customer service.
ANA H O O K E R
V I C E P R E S I D E N T, C L I N I C A L L A B O R A T O R Y O P E R A T I O N S

8
Key Responsibility: Oversee accounting, financial analysis, treasury
and billing
Previous Employment: president of IT infrastructure outsourcing,
Telephone & Data Systems, Inc (TDS); chief financial officer, telcom
subsidiary, TDS; director, PriceWaterhouseCoopers, LLP
Education: MBA, Cornell University; BA, University of
Wisconsin-Madison
Industry Organizations: Chartered Financial Analyst
Exact Sciences is a fantastically fast-paced company on a
noble mission. While the company is focused on its first mission—
helping eradicate colorectal cancer—it is also working very hard to
develop additional products to help eliminate other cancers.
BILL M E G A N
S E N I O R V I C E P R E S I D E N T, F I N A N C E

Key Responsibility: Oversee talent acquisition, organizational design,
employee relations, development and engagement
Previous Employment: human resources manager, GE Healthcare;
manager and project director, University of Wisconsin Survey Center
Education: MBA, BS, University of Wisconsin-Madison
Industry Organizations: Society for Human Resource
Management (SHRM)
Exact Sciences’ people take great pride in their work and are
dedicated to a common mission that we are driving toward
together. I see a genuine commitment to the success of the
team—not just the success of individuals. Our people are
authentic, focused and share a common purpose: we are all
playing a role in eradicating colon cancer.
SARAH C O N D E L L A
V I C E P R E S I D E N T, H U M A N R E S O U R C E S

10
Key Responsibility: Lead the customer-facing sales team, training
and operations
Previous Employment: vice president, sales, Novartis Vaccines;
director, head of operations, senior product manager, head of sales
training, GlaxoSmithKline Vaccines
Education: BS (Honors), University of Edinburgh, Scotland
There are two key aspects of Exact Sciences that excite me. The
culture has attracted a team of knowledgeable, innovative and
driven people who are passionate about what they do to ensure
Cologuard’s success. And the innovation here not only impacts
how colon cancer is screened and diagnosed but also has led to
a robust pipeline of future diagnostics for other cancers.
DIANE R O G E R S
V I C E P R E S I D E N T, S A L E S

Key Responsibility: Build focused clinical messages and
publications demonstrating the medical value of Cologuard
Previous Employment: medical director, Quest Diagnostics Nichols
Institute, Valencia CA; chief medical officer, bioTheranostics
(bioMérieux); chief medical officer, Roche Molecular Diagnostics;
vice president, pathology services, Genzyme Genetics (now
LabCorp); vice president, laboratory director, Specialty Laboratories
(now Quest); chief of pathology and laboratories, UCLA Santa
Monica Hospital
Education: MD, University of Arizona College of Medicine;
BS, University of Notre Dame
Industry Organizations: College of American Pathologists (CAP):
Section Editor (Clinical Efficacy and Economics), CAP Archives
of Pathology and Laboratory Medicine; CAP Economic Affairs
Committee; CAP House of Delegates
I have a fantastic personal opportunity to lead the medical affairs
team for a growing company with a novel product, Cologuard. As a
result, I enjoy bringing physicians up to speed on the medical value
of Cologuard. We also have a fantastic corporate opportunity to
expand our efforts globally to help prevent colon cancer and
other major cancers outside the United States.
MICHAEL D U G A N
S E N I O R V I C E P R E S I D E N T,
C L I N I C A L D E V E L O P M E N T A N D M E D I C A L A F F A I R S

12
Key Responsibility: Build relationships with key strategic academic,
research, clinical, political, medical, professional and patient
advocacy groups
Previous Employment: managed care executive; chair, Department
of Pathology and Laboratory Medicine, Harvard Pilgrim Healthcare;
faculty, Harvard Medical School
Education: Postdoctoral Fellow, Immunology/Oncology, University
of Pennsylvania School of Medicine; MD, University of Pennsylvania
School of Medicine; BS, University of Miami
It really does take a team and a lot of patience to move
a mountain. But colorectal cancer is a preventable disease,
and I’m proud of contributing to significantly changing the face of
health care for an at-risk population.
BARRY B E R G E R
C H I E F M E D I C A L O F F I C E R , M E D I C A L A F F A I R S

Key Responsibility: Develop and execute comprehensive regulatory
and clinical strategies; maintain regulatory compliance for all
commercialized products
Previous Employment: director/associate director, clinical operations,
Quintiles; director, clinical affairs, Third Wave Technologies
Education: MS, BS, University of Wisconsin-Madison
Industry Organizations: Association of Clinical Research
Professionals (ACRP); Drug Information Association (DIA);
Regulatory Affairs Professionals Society (RAPS)
I am proud to have helped deliver the 10-0 vote in favor of
Cologuard at the FDA Advisory Panel, followed closely by the FDA
approval of Cologuard. The panel vote and subsequent approval
are great examples of how team efforts at Exact Sciences lead to
outstanding accomplishments.
SANDRA S TAT Z
V I C E P R E S I D E N T, C L I N I C A L , Q U A L I T Y A N D R E G U L A T O R Y

14
Key Responsibility: Align information technology services
with the priorities of the business
Previous Employment: co-founder and president, Performance G2,
Inc.; executive vice president, Eclipse Networks, Inc; founder and
president, Systems Solutions Group, Inc.
Education: MBA, Haas School; University of California, Berkeley;
BS and BBA, University of Wisconsin-Madison
Industry Organizations: IBM Business Intelligence Partners Advisory
Board, 2010-2011; Chair of Northern California Cognos User Group,
2004-2006
It is energizing and very motivating to help eradicate
a disease like colorectal cancer. Leveraging data in
sophisticated ways to make better business decisions is at
the core of any successful company today. Being able to work
every day with outstanding people on such a compelling health
issue is extremely rewarding.
GARY F R I N G S
C H I E F I N F O R M A T I O N O F F I C E R

Key Responsibility: Develop new products from feasibility through
product launch, conduct performance studies for FDA submissions
and support existing product lines
Previous Employment: vice president of product development,
Eppendorf 5 Prime; director of product development, Hologic
(formally Third Wave Technologies)
Education: PhD, University of Wisconsin, Milwaukee;
BA, University of Wisconsin-Parkside
At Exact Sciences, I have the opportunity to do the work that I enjoy
most: being able to assess, optimize and adapt new technologies.
Creating cutting-edge diagnostic products that can improve
or save lives is very rewarding.
MIKE D O M A N I C O
V I C E P R E S I D E N T, P R O D U C T D E V E L O P M E N T

16
Key Responsibility: Oversee the production of reagent kits and
collection kits utilized to conduct colon cancer screening tests
Previous Employment: site leader, Thermo Fisher Scientific; director,
operations, Thermo Fisher Scientific (formerly Life Technologies and
Invitrogen)
Education: PhD, University of Minnesota-Twin Cities; BS, University
of Wisconsin-Madison
Industry Organizations: Society of Laboratory Automation and
Screening; Executive Sponsor of iWIN (International Women’s
Influential Network)
At Exact Sciences, I work every day with an extremely talented
team of employees who are all focused on delivering world-
class service to our customers. We are making a real difference
in people’s lives through the early diagnosis and prevention of
colon cancer.
TAMMY T U R E K - E T I E N N E
V I C E P R E S I D E N T, O P E R A T I O N S

Key Responsibility: Lead the research and development systems
department, developing the instrumentation and software used with
Cologuard and future Exact Sciences’ products
Previous Employment: senior staff scientist, Gen-Probe, Inc.;
director, product development, Nanogen, Inc.
Education: PhD, Columbia University; BS, Miami University
Exact Sciences has the right mix of people, technology and
challenging work. Every day is a great day when you are making
products that help beat cancer.
JAMES L I G H T
V I C E P R E S I D E N T, S Y S T E M S D E V E L O P M E N T

18
Key Responsibility: Lead strategic planning and business
development initiatives
Previous Employment: vice president of strategy, portfolio
management & business development, early technologies/surgical
division, Covidien (now Medtronic)
Education: MBA, Loyola University; BA, University of Northern Iowa
Health care needs to move from reactive to proactive care, and we
have a long way to go. Very few companies in health care
are disrupting diseases on as many levels as Exact Sciences.
The model created here will be copied in many ways,
for many years to come.
MICHAEL M I N E T T E
V I C E P R E S I D E N T, B U S I N E S S D E V E L O P M E N T & S T R A T E G Y

Key Responsibility: Launch Cologuard in Europe and the Middle East
Previous Employment: vice president, Europe, Cytyc/Hologic
Education: Epsom College, London
I joined Exact Sciences to drive the implementation of new and
innovative cancer screening products. We are changing current
medical practice and saving lives. I see only stellar growth in
our future.
WAYNE TAY L O R
V I C E P R E S I D E N T A N D H E A D O F E U R O P E A N D M I D D L E E A S T

20
Key Responsibility: Commercialize Cologuard and Exact Sciences’
pipeline products in Asia Pacific
Previous Employment: chief executive officer and president,
Wafergen BioSystems; senior vice president genomics, Third Wave
Technologies; vice president research operations, Pharmacia;
director, new products oncology, Johnson & Johnson
Education: PhD, University of California, Los Angeles; MBA, Wharton
School, University of Pennsylvania; BA, Hampton University
There are a lot of reasons I came to Exact Sciences: I get to work
with a world-class management team that I already know well.
I get to work in a can-do environment. And I get to help fight
cancer and provide life-saving solutions for patients worldwide.
IVAN T R I F U N O V I C H
V I C E P R E S I D E N T A N D H E A D O F A S I A P A C I F I C

KEY A C C O M P L I S H M E N T S
• Publication of DeeP-C clinical trial results in the New England
Journal of Medicine
• Approval of Cologuard by the US Food and Drug Administration
• Coverage and payment decisions by the Centers for Medicare
and Medicaid Services
• The early launch of Cologuard and its strong launch trajectory
• Product development partnerships with Mayo Clinic and
The University of Texas MD Anderson Cancer Center

22
2015 P R I O R I T I E S
• Continuing to grow the Cologuard business
• Providing world-class service to physicians and patients through
our customer care center
• Continuing to advance a valuable, clinically important pipeline
of products

EXACT SCIENCES CORPORATION
441 Charmany Drive, Madison, WI 53719
www.ExactSciences.com | www.ExactLabs.com
1-844-870-8870
Cologuard is a registered trademark of Exact Sciences Corporation.
©2015 Exact Sciences Corporation. All rights reserved. ES24429-0615

Exact Leaders Driving Cancer Detection

Recommandé

Recommandé

Contenu connexe

En vedette

En vedette (15)

Similaire à Exact Leaders Driving Cancer Detection

Similaire à Exact Leaders Driving Cancer Detection (20)

Plus de Exact Sciences

Plus de Exact Sciences (20)

Dernier

Dernier (20)

Exact Leaders Driving Cancer Detection